Literature DB >> 12467250

MyD88 as a bottle neck in Toll/IL-1 signaling.

O Takeuchi1, S Akira.   

Abstract

Myeloid differentiation factor 88 (MyD88) is an adaptor molecule composed of an N-terminal death domain and a C-terminal Toll/interleukin (IL)-1R homology domain. Ligand binding to Toll-like receptor (TLR)/IL-1R family members results in the association of MyD88 to the cytoplasmic tail of receptors; this then initiates the signaling cascade that leads to the activation of nuclear factor-kappa B and mitogen-activated protein kinases. Analysis of MyD88-deficient mice revealed its essential role in TLR/IL-1R signaling as well as in both the innate and the adaptive immune response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467250     DOI: 10.1007/978-3-642-59430-4_10

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  59 in total

1.  Toll-like receptor ligands directly promote activated CD4+ T cell survival.

Authors:  Andrew E Gelman; Jidong Zhang; Yongwon Choi; Laurence A Turka
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

2.  Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses.

Authors:  Camilo Cuadros; Francisco J Lopez-Hernandez; Ana Lucia Dominguez; Michael McClelland; Joseph Lustgarten
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

3.  IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).

Authors:  Zhihong Chen; Lingkai Su; Qingan Xu; Jenny Katz; Suzanne M Michalek; Mingwen Fan; Xu Feng; Ping Zhang
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

4.  Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4.

Authors:  Giuseppe Mancuso; Angelina Midiri; Carmelo Biondo; Concetta Beninati; Maria Gambuzza; Daniele Macrì; Antonella Bellantoni; Andrej Weintraub; Terje Espevik; Giuseppe Teti
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  MEKK3 is essential for lipopolysaccharide-induced interleukin-6 and granulocyte-macrophage colony-stimulating factor production in macrophages.

Authors:  Kihwan Kim; Omar Duramad; Xiao-Feng Qin; Bing Su
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

Review 6.  Development of adjunctive therapies for bacterial meningitis and lessons from knockout mice.

Authors:  Robert Paul; Uwe Koedel; Hans-Walter Pfister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 7.  Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.

Authors:  Okom Nkili F C Ofodile
Journal:  J Ind Microbiol Biotechnol       Date:  2007-09-05       Impact factor: 3.346

8.  Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

Authors:  Alexander J Muller; Madhav D Sharma; Phillip R Chandler; James B Duhadaway; Mary E Everhart; Burles A Johnson; David J Kahler; Jeanene Pihkala; Alejandro Peralta Soler; David H Munn; George C Prendergast; Andrew L Mellor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

9.  Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract.

Authors:  Patricia A Pioli; Eyal Amiel; Todd M Schaefer; John E Connolly; Charles R Wira; Paul M Guyre
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  Imbalance between HDAC and HAT activities drives aberrant STAT1/MyD88 expression in macrophages from type 1 diabetic mice.

Authors:  Luciano Ribeiro Filgueiras; Stephanie L Brandt; Theresa Raquel de Oliveira Ramalho; Sonia Jancar; C Henrique Serezani
Journal:  J Diabetes Complications       Date:  2016-08-07       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.